Jazz Pharmaceuticals plc Annual Net Income (Loss) Attributable to Parent in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Jazz Pharmaceuticals plc quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2010 to 2023.
  • Jazz Pharmaceuticals plc Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was $215M, a 46.5% increase year-over-year.
  • Jazz Pharmaceuticals plc Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was $463M, a 479% increase year-over-year.
  • Jazz Pharmaceuticals plc annual Net Income (Loss) Attributable to Parent for 2023 was $415M.
  • Jazz Pharmaceuticals plc annual Net Income (Loss) Attributable to Parent for 2022 was -$224M, a 32% increase from 2021.
  • Jazz Pharmaceuticals plc annual Net Income (Loss) Attributable to Parent for 2021 was -$330M, a 238% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $415M +$639M Jan 1, 2023 Dec 31, 2023 10-K 2024-02-28
2022 -$224M +$106M +32% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-28
2021 -$330M -$568M -238% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-28
2020 $239M -$285M -54.4% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-01
2019 $523M +$76.3M +17.1% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-01
2018 $447M -$40.8M -8.35% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-23
2017 $488M +$91M +22.9% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-25
2016 $397M +$67.3M +20.4% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-26
2015 $330M +$271M +464% Jan 1, 2015 Dec 31, 2015 10-K 2018-02-27
2014 $58.4M -$158M -73% Jan 1, 2014 Dec 31, 2014 10-K 2017-02-28
2013 $216M -$72.3M -25% Jan 1, 2013 Dec 31, 2013 10-K 2016-02-23
2012 $289M +$164M +131% Jan 1, 2012 Dec 31, 2012 10-K 2015-02-24
2011 $125M +$92.2M +281% Jan 1, 2011 Dec 31, 2011 10-K 2014-02-25
2010 $32.8M Jan 1, 2010 Dec 31, 2010 10-K 2013-02-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.